Veracyte lung cancer test could help avoid some risky biopsies

Washington PostVeracyte lung cancer test could help avoid some risky biopsiesReutersA new diagnostic test from Veracyte Inc could help many people avoid risky and costly invasive lung biopsies at a time when millions of American smokers are eligible for lung cancer screening, according to data from studies presented on Sunday.New test could sharply reduce risky, costly lung cancer biopsiesWashington PostPublic Release: 17-May-2015 Study validates effectiveness of genomic test for ...EurekAlert (press release)all 5 news articles »

Share this post